Physiology and pharmacology of dopamine D2-receptors: their implications in dopamine-substitute therapy for Parkinson's disease.
Mercuri
N B
NB
Clinica Neurologica, II Universitá degli Studi di Roma, Tor Vergata, Italy.
Calabresi
P
P
Bernardi
G
G
D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D008564:Membrane Potentials; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D015221:Potassium Channels / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D017448:Receptors, Dopamine D2; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology
D015259:Dopamine Agents; D015221:Potassium Channels; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D004298:Dopamine